Beylerli Ozal, Beilerli Aferin, Shumadalova Alina, Wang Xiaoxiong, Yang Mingchun, Sun Hanran, Teng Lei
Рeoples' Friendship University of Russia (RUDN University), Moscow, Russia.
Department of Obstetrics and Gynecology, Tyumen State Medical University, Tyumen, Russia.
Front Cell Dev Biol. 2022 Oct 4;10:1036809. doi: 10.3389/fcell.2022.1036809. eCollection 2022.
Glioblastoma (GBM) is the most common and aggressive tumor of the central nervous system, which has a highly invasive growth pattern, which creates poor prospects for patient survival. Chemotherapy and tumor surgery are limited by anticancer drug resistance and tumor invasion. Evidence suggests that combinations of treatments may be more effective than single drugs alone. Natural polyphenolic compounds have potential as drugs for the treatment of glioblastoma and are considered as potential anticancer drugs. Although these beneficial effects are promising, the efficacy of natural polyphenolic compounds in GBM is limited by their bioavailability and blood-brain barrier permeability. Many of them have a significant effect on reducing the progression of glioblastoma through mechanisms such as reduced migration and cell invasion or chemosensitization. Various chemical formulations have been proposed to improve their pharmacological properties. This review summarizes natural polyphenolic compounds and their physiological effects in glioblastoma models by modulating signaling pathways involved in angiogenesis, apoptosis, chemoresistance, and cell invasion. Polyphenolic compounds are emerging as promising agents for combating the progression of glioblastoma. However, clinical trials are still needed to confirm the properties of these compounds and .
胶质母细胞瘤(GBM)是中枢神经系统最常见且侵袭性最强的肿瘤,具有高度侵袭性的生长模式,这使得患者的生存前景不佳。化疗和肿瘤手术受到抗癌药物耐药性和肿瘤侵袭的限制。有证据表明,联合治疗可能比单一药物更有效。天然多酚类化合物具有作为治疗胶质母细胞瘤药物的潜力,被视为潜在的抗癌药物。尽管这些有益效果很有前景,但天然多酚类化合物在胶质母细胞瘤中的疗效受到其生物利用度和血脑屏障通透性的限制。它们中的许多通过减少迁移和细胞侵袭或化学增敏等机制,对减缓胶质母细胞瘤的进展有显著作用。人们已经提出了各种化学制剂来改善它们的药理特性。本综述通过调节参与血管生成、细胞凋亡、化疗耐药性和细胞侵袭的信号通路,总结了天然多酚类化合物及其在胶质母细胞瘤模型中的生理作用。多酚类化合物正成为对抗胶质母细胞瘤进展的有前景的药物。然而,仍需要临床试验来证实这些化合物的特性。